Synmosa Biopharma Corporation (TPEX: 4114)
Taiwan
· Delayed Price · Currency is TWD 37.95
+0.30 (0.80%)
Sep 10, 2024, 1:30 PM CST
Synmosa Biopharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 689.09 | 594.83 | 799.09 | 303.86 | 638.11 | 47.09 | Upgrade
|
| Depreciation & Amortization | 336.83 | 334.83 | 315.64 | 297.29 | 296.7 | 256.36 | Upgrade
|
| Other Amortization | 5.55 | 5.09 | 4.74 | 4.77 | 5.46 | 5.83 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.13 | -0.12 | -281.43 | -11.86 | -0.68 | -0.82 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.47 | 10.86 | 15.22 | 8.21 | 44.32 | 17 | Upgrade
|
| Loss (Gain) From Sale of Investments | -51.84 | -49.82 | -50.41 | -4.75 | -233.52 | 0.05 | Upgrade
|
| Loss (Gain) on Equity Investments | 11.78 | 10.33 | 16.56 | 16.4 | 1.54 | 11.84 | Upgrade
|
| Stock-Based Compensation | 14.1 | 17.21 | 22.47 | 10.64 | 4.3 | 9.45 | Upgrade
|
| Provision & Write-off of Bad Debts | 4.41 | 6.74 | 3.41 | 1.82 | 9.94 | 3.37 | Upgrade
|
| Other Operating Activities | -145.34 | -98.04 | -59.33 | -147.25 | -275.64 | -243.46 | Upgrade
|
| Change in Accounts Receivable | 24.88 | -27.87 | -244.16 | -77.74 | -13.62 | -39.12 | Upgrade
|
| Change in Inventory | -149.71 | -305.39 | -120.94 | 16.87 | -172.66 | -177.7 | Upgrade
|
| Change in Accounts Payable | -75.11 | -8.09 | 147.95 | 65.26 | -114.81 | 114.31 | Upgrade
|
| Change in Unearned Revenue | -70.4 | 1.21 | 46.36 | -2.44 | -1.85 | 11.99 | Upgrade
|
| Change in Other Net Operating Assets | -65.44 | 20.15 | 15.08 | -26.21 | 51.51 | -61.08 | Upgrade
|
| Operating Cash Flow | 531.15 | 511.93 | 630.25 | 454.86 | 254.4 | -44.88 | Upgrade
|
| Operating Cash Flow Growth | -13.44% | -18.77% | 38.56% | 78.80% | - | - | Upgrade
|
| Capital Expenditures | -269.52 | -207.04 | -129.3 | -93.06 | -154.41 | -183.37 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.71 | 1.62 | 305.18 | 240.57 | 9.65 | 1.19 | Upgrade
|
| Cash Acquisitions | - | -48.83 | -95.86 | -7.52 | 82.91 | -244.36 | Upgrade
|
| Sale (Purchase) of Intangibles | -26.4 | -53.48 | -55.03 | -49.07 | -22.8 | -18.87 | Upgrade
|
| Investment in Securities | -293.39 | -402.88 | -96.92 | -2.12 | 90.55 | -27.29 | Upgrade
|
| Other Investing Activities | 9.99 | -7.25 | 2.59 | -15.48 | 28.59 | -126.08 | Upgrade
|
| Investing Cash Flow | -574.62 | -717.87 | -69.33 | 73.33 | 34.5 | -598.79 | Upgrade
|
| Short-Term Debt Issued | - | 127.07 | - | 133 | - | 248.57 | Upgrade
|
| Long-Term Debt Issued | - | 493 | 350 | - | 1,683 | 946.48 | Upgrade
|
| Total Debt Issued | 418.37 | 620.07 | 350 | 133 | 1,683 | 1,195 | Upgrade
|
| Short-Term Debt Repaid | - | -50 | -179.76 | - | -756 | - | Upgrade
|
| Long-Term Debt Repaid | - | -1,532 | -344.65 | -381.84 | -892.37 | -391.02 | Upgrade
|
| Total Debt Repaid | -1,389 | -1,582 | -524.41 | -381.84 | -1,648 | -391.02 | Upgrade
|
| Net Debt Issued (Repaid) | -970.64 | -962.15 | -174.41 | -248.84 | 35.05 | 804.03 | Upgrade
|
| Issuance of Common Stock | - | 950 | 40.23 | 0.61 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -108.97 | -51.64 | - | -199.97 | Upgrade
|
| Common Dividends Paid | -194.43 | -194.43 | -148.64 | -79.98 | -45.7 | -38.02 | Upgrade
|
| Other Financing Activities | 252.35 | 243.83 | 43.84 | 82.28 | -101.14 | 97.16 | Upgrade
|
| Financing Cash Flow | -912.73 | 37.24 | -347.95 | -297.57 | -111.78 | 663.19 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5.87 | -0.39 | 6.52 | -0.81 | -3.88 | -1.5 | Upgrade
|
| Net Cash Flow | -950.33 | -169.09 | 219.48 | 229.82 | 173.24 | 18.02 | Upgrade
|
| Free Cash Flow | 261.63 | 304.89 | 500.95 | 361.81 | 100 | -228.25 | Upgrade
|
| Free Cash Flow Growth | -41.29% | -39.14% | 38.46% | 261.83% | - | - | Upgrade
|
| Free Cash Flow Margin | 5.05% | 5.93% | 11.42% | 11.18% | 3.29% | -8.52% | Upgrade
|
| Free Cash Flow Per Share | 0.62 | 0.75 | 1.28 | 0.91 | 0.26 | -0.65 | Upgrade
|
| Cash Interest Paid | 58.74 | 66.97 | 59.29 | 51.82 | 53.42 | 47.88 | Upgrade
|
| Cash Income Tax Paid | 181.8 | 172.08 | 69.76 | 65.01 | 9.63 | 75.52 | Upgrade
|
| Levered Free Cash Flow | 139.32 | 148.45 | 362.14 | 420.14 | -282.46 | -342.49 | Upgrade
|
| Unlevered Free Cash Flow | 176.23 | 190.44 | 399.33 | 452.62 | -249.45 | -308.51 | Upgrade
|
| Change in Net Working Capital | 301.93 | 291.68 | 47.14 | -165.34 | 472.14 | 311.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.